Corporate Partners

Our Society is supported by a cross-section of industry, allowing us to meet our charitable aims.

We recognise that rapid advances in medical science are more likely to be brought into clinical practice when academia, charities and industry collaborate together in an open way.

We are transparent around the nature of the Society's relationships with commercial partners. We adhere to strict guidelines to ensure the Society remains independent without undue influence from external organisations.

Society Partner

HRA Pharma Rare Diseases

By partnering with your extraordinary community, HRA Pharma Rare Diseases has a personal commitment to playing our part in tackling current challenges, reducing the time to accurate diagnosis, enabling global access to treatment and optimising long-term management.

Sandoz

Sandoz is a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.

Recordati Rare Diseases

Recordati Rare Diseases UK is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990 (as Orphan Europe), Recordati Rare Diseases is active in the field of rare diseases.